Table 3. Baseline Characteristics and Medical History of the Patients in BioMime™ and XIENCE Arm [15].
Variables | BioMime™ SES (N = 170) | XIENCE EES (N = 86) | P-value (BioMime™ SES vs. XIENCE EES) |
---|---|---|---|
Age (years), mean ± SD | 64.33 ± 9.57 | 64.70 ± 8.99 | 0.75 |
Male, n (%) | 111 (65.29) | 53 (61.63) | 0.56 |
Body mass index (kg/m2) | 28.64 ± 4.45 | 29.40 ± 4.39 | 0.20 |
Cardiac risk factors, n (%) | |||
Diabetes mellitus | 41 (24.12) | 18 (20.93) | 0.57 |
Hypertension | 125 (73.53) | 68 (79.07) | 0.11 |
Dyslipidemia | 118 (69.41) | 59 (68.60) | 0.89 |
Chronic lung disease | 9 (5.29) | 10 (11.63) | 0.07 |
Smokers | 71 (41.76) | 41 (47.67) | 0.37 |
History of CAD | 67 (39.41) | 29 (33.72) | 0.37 |
Renal insufficiency | 4 (2.35) | 2 (2.33) | 0.99 |
Previous MI | 37 (21.76) | 13 (15.12) | 0.25 |
Previous PCI | 31 (18.24) | 14 (16.28) | 0.69 |
Cardiac status, n (%) | |||
Stable angina | 116 (68.24) | 61 (70.9) | 0.66 |
Unstable angina | 25 (14.71) | 12 (13.95) | 0.87 |
Asymptomatic | 16 (9.41) | 5 (5.81) | 0.32 |
STEMI | 3 (1.76) | 0 (0.0) | 0.25 |
NSTEMI | 10 (5.88) | 8 (9.3) | 0.31 |
LVEF, % | 55.86 ± 7.22 | 56.82 ± 10.13 | 0.40 |
CAD: coronary artery disease; LVEF: left ventricular ejection fraction; MI: myocardial infarction; N: number of patients; PCI: percutaneous coronary intervention; SD: standard deviation; ST: stent thrombosis; STEMI: ST elevation myocardial infarction.